Micro-Tech 南微医学
4 significant filings since 1 Jun 2026: 2 on regulatory inquiry and 2 on dividend. The latest, on 27 Aug 2026: 2026-016 南微医学科技股份有限公司关于2026年半年度利润分配方案的公告.
自 1 Jun 2026 起有 4 份重大公告：regulatory inquiry 2 份、dividend 2 份。最新一份（27 Aug 2026）：2026-016 南微医学科技股份有限公司关于2026年半年度利润分配方案的公告。
Price History 价格走势
1,250 trading days 个交易日 · High 最高 ¥195.14 · Low 最低 ¥54.31The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
No broker has changed its rating on this company in the reports held.
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 东吴证券 | 朱国广 | Buy 买入 | 31 Aug 2026 | 2 | — |
| 国信证券 | 陈曦炳,彭思宇,凌珑 | Outperform 增持 | 30 Aug 2026 | 2 | — |
| 招银国际 | Cathy WANG,Jill Wu | Buy 买入 | 28 Aug 2026 | 2 | 90.60 |
| 国金证券 | 甘坛焕,何冠洲 | Buy 买入 | 27 Aug 2026 | 4 | — |
| 西南证券 | 杜向阳,陈辰 | Unrated | 8 May 2026 | 1 | — |
| 太平洋 | 谭紫媚,李啸岩 | Buy 买入 | 9 Nov 2025 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 2 of 12 reports. 每行为该券商近十二个月的最新研报；12 份中 2 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。